Unblinding Update Email, December 7, 2010 - Laviv

From: Lim, Agnes
  Sent: Tuesday, December 07, 2010 10:54 AM
  To: 'Jeanne Novak'; Dana Weinberger
  Cc: Schneider, Bruce; Zhu, Yao-Yao; Haudenschild, Changting; Lee, Shiowjen; Thomas, John; Tull, Lori
  Subject: RE: Unblinding Update

Jeanne; Dana:

You have adequately addressed our questions and comments regarding your proposal to unblind the Biopsy 1 data for the statistical analysis. You may proceed with your plans to unblind the IT-H-001 data.

Please contact us if you have any additional questions. Thank you.

Agnes

--------------------------------------------------------------------------------

 

, Lori
  Cc: Schneider, Bruce; Lim, Agnes; Zhu, Yao-Yao; Thomas, John; Dana Weinberger
  Subject: Unblinding Update
 

Dear Lori,

 

I just wanted to let you and the FDA team to know that I am in the UK for the next two days at an EMA meeting.  Thus, Dana will be contacting you today to check on the status of the review to allow Fibrocell to unblind the IT-H-001 data.

 

Of course I am available by email and cell phone if I am needed.  Otherwise, please note that Dana will be the primary FDA contact for the next two days.

 

Best regards,

 

Jeanne

 

Jeanne M. Novak, Ph.D.

CEO and Principal Consultant

CBR International Corp.®

720-746-1190

720-746-1192 (Fax)

www.cbrintl.com

 

This electronic transmission (including any and all attachments) is intended solely for the use of the individual or entity to whom it is addressed and may contain information that is privileged and/or confidential. If you are not the intended recipient of this electronic transmission, you are hereby notified that any disclosure, copying or distribution, or the taking of any action in reliance upon the contents of this electronic transmission, is strictly prohibited, and you are further requested to purge this electronic transmission and all copies thereof from your computer system.